A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3B STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DIFFERENT RETATRUTIDE DOSE ESCALATION SCHEMES IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR OVERWEIGHT: A RANDOMIZED, CONTROLLED, DOUBLE-BLIND TRIAL (TRIUMPH-9)

Intervention/treatment:
RETATRUTIDE (LY3437943)
Medical condition:
OVERWEIGHT/OBESITY
Protocol code:
J1I-MC-GZQL
Control number:
303787
Status:
Active, not recruiting
Approved:
December 10, 2025
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT07357415
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Role
CONTACT
Phone:
1-317-615-4559
Name
Physicians interested in becoming principal investigators please contact
Role
CONTACT
Sponsor
ELI LILLY CANADA INC

Locations

Aggarwal and Associates Limited
Brampton, L6T 0G1
Recruiting
Role
CONTACT
Phone:
9054589033
Name
Naresh Aggarwal
Role
PRINCIPAL_INVESTIGATOR
C.I.C. Mauricie inc.
Trois-Rivières, G8T 7A1
Recruiting
Name
Pierre-Alexandre Menard
Role
PRINCIPAL_INVESTIGATOR
Canadian Phase Onward
Toronto, M3J 0K2
Recruiting
Role
CONTACT
Phone:
416-227-0543
Name
Steven Orlov
Role
PRINCIPAL_INVESTIGATOR
Diex Recherche Inc. Division Joliette
Joliette, J6E 6A9
Recruiting
Name
Julien Du Tremblay
Role
PRINCIPAL_INVESTIGATOR
Diex Recherche Inc. Division Quebec
Québec, G1V 4T3
Recruiting
Name
Isabelle Labonte
Role
PRINCIPAL_INVESTIGATOR
Diex Recherche Inc. Division Sherbrooke
Sherbrooke, J1L 0H8
Recruiting
Role
CONTACT
Phone:
8193462887
Name
Ginette Girard
Role
PRINCIPAL_INVESTIGATOR
Dr. Anil K. Gupta Medicine Professional Corporation
Toronto, M9V 4B4
Recruiting
Role
CONTACT
Phone:
6473442020
Name
Anil Gupta
Role
PRINCIPAL_INVESTIGATOR
Med Trust Research
Courtice, L1E 2J5
Recruiting
Name
Anojan Kathirkamanayagan
Role
CONTACT
Phone:
905-728-7915 ext. 5
Name
Anojan Kathirkamanayagan
Role
PRINCIPAL_INVESTIGATOR
Milestone Research Inc.
London, N5W 6A2
Recruiting
Role
CONTACT
Phone:
5196594040
Name
Peter Dzongowski
Role
PRINCIPAL_INVESTIGATOR
Winterberry Research Inc.
Hamilton, L8J 0B6
Recruiting
Role
CONTACT
Phone:
365-366-6267
Name
Steven Zizzo
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources